SEC EDGAR CompanyFacts fact · reporting period
NAVIDEA BIOPHARMACEUTICALS, INC.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$2.054M{"amount": 2054096, "concept": "us-gaap:Revenues", "currency": "USD"}- Metric
- revenue
- Period
- 2014-01-01 – 2014-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T12:53:23.754570+02:00
Raw response SHA-256
e6e15b291454205779be87d7d17e8689…Official-identifier path
https://factanker.com/fact/sec/cik-0000810509/revenue/2014-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 13200, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001437749-17-020777)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.